Clinical Trials Logo
  1. Home
  2. Neonatal Seizures
  3. NCT02160171

ANSeR- The Algorithm for Neonatal Seizure Recognition Study — ANSeR  

Neonatal Seizures Clinical Trial

Official title:
A Multicentre Clinical Evaluation of a Decision Support Algorithm for Neonatal Seizure Detection

Clinical Trial Summary

A Multicentre Clinical Evaluation of a Decision Support Algorithm for Neonatal Seizure Detection: ANSeR

Clinical Trial Description

This is a multi-centre study. It will be based on routine clinical practice but will also allow for the off-line retrospective application of ANSeR to a well-defined clinical population in order to establish the potential diagnostic utility of the algorithm. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02160171
Study type Observational
Source University College Cork
Contact
Status Completed
Phase N/A
Start date April 2013
Completion date June 2015
View Details
See also
  Status Clinical Trial Phase
Terminated NCT01089504 - Prophylactic Phenobarbital After Neonatal Seizures Phase 4
Terminated NCT02550028 - Levetiracetam Treatment of Neonatal Seizures Phase 1/Phase 2
Completed NCT02789176 - Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study
Not yet recruiting NCT02602015 - Levetiracetam Treatment of Neonatal Seizures Phase 1/Phase 2
Terminated NCT01475656 - Efficacy of Keppra for Neonatal Seizures N/A
Recruiting NCT03107507 - Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEG Phase 4
Completed NCT01720667 - Efficacy of Intravenous Levetiracetam in Neonatal Seizures Phase 1/Phase 2
Recruiting NCT05079971 - EAGLET: EEG vs aEEG to Improve the Diagnosis of neonataL Seizures and Epilepsy N/A
Completed NCT02229123 - Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study Phase 2
Completed NCT01434225 - NEMO1:NEonatal Seizure Using Medication Off-patent Phase 1/Phase 2